Volume 74, Issue 5 pp. 951-955
Article
Full Access

[5-Leucin]enkephalin-Related Glycoconjugates: Structurally Novel Agents Effective against HIV-1

Štefica Horvat

Corresponding Author

Štefica Horvat

Department of Organic Chemistry and Biochemistry, ‘Ruder Bošcarković’ Institute, P.O.B. 1016, 41001 Zagreb, Yugoslavia

Department of Organic Chemistry and Biochemistry, ‘Ruder Bošcarković’ Institute, P.O.B. 1016, 41001 Zagreb, YugoslaviaSearch for more papers by this author
Lidija Varga

Lidija Varga

Department of Organic Chemistry and Biochemistry, ‘Ruder Bošcarković’ Institute, P.O.B. 1016, 41001 Zagreb, Yugoslavia

Search for more papers by this author
Jaroslav Horvat

Jaroslav Horvat

Department of Organic Chemistry and Biochemistry, ‘Ruder Bošcarković’ Institute, P.O.B. 1016, 41001 Zagreb, Yugoslavia

Search for more papers by this author
Andreas Pfützner

Andreas Pfützner

Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Erlich-Str. 42–44, D–6000 Frankfurt 70

Search for more papers by this author
Haryadi Suhartono

Haryadi Suhartono

Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Erlich-Str. 42–44, D–6000 Frankfurt 70

Search for more papers by this author
Helga Rübsamen-Waigmann

Helga Rübsamen-Waigmann

Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Erlich-Str. 42–44, D–6000 Frankfurt 70

Search for more papers by this author
First published: 7 August 1991
Citations: 9

Abstract

A series of [Leu5]enkephalin-related glycoconjugates with an ester-, ether-, or amide-type linkage were synthesized and evaluated for antiviral activity against HIV-1 in a cell-culture system using peripheral blood lymphocytes. All tested glycoconjugates exhibited a certain antiviral activity which was significantly higher than the activity of the parent peptide compound itself. These results indicate that synthetic glycoconjugates of opioid peptides are good candidates for the development of anti-HIV agents.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.